Amedica Corporation is a commercial-stage biomaterial company. It is engaged in using its silicon nitride technology platform to develop, manufacture & commercialize medical devices. Its products include valeo interbody fusion devices & facet fixation.
SALT LAKE CITY, UT -- (Marketwired) -- 04/18/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, is pleased to announce a partnership with Shandong Weigao Orthopedic Device Company Limited ("Weigao Orthopedic"), a subsidiary of Shandong Weigao Group Medical Polymer Company Limited (HKSE: 1066), a medical device company in China specializing in the R&D, production and sale of spine, trauma and joint orthopedic implants.
Well well well been waiting for this FDA for a good year and a half. Let's see how this plays out - will not engage in position
If hedge funds open some positions here we may see a jump to the double digits..we only need good news and a spark..
From their recent press-release: they expect the sales and marketing expenses will rise slightly due to the implementation of the sales strategy during the third quarter of 2017. Additionally, they expect the commissions to increase in absolute terms over time but remain approximately the same or decrease as a percentage of product revenue.